FAP-targeted CAR T-cell therapy: A promising approach for the treatment of Peyronie’s disease
Authors:
- Ali ŞahinAŞAli Şahin
- Huseyn BabayevHBHuseyn Babayev
- Murat GülMGMurat Gül
- 4 August 2023
- journal article
- research article
- Published by Elsevier in Medical Hypotheses
- Vol. 178
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Evidence-Based Management Guidelines on Peyronie's DiseaseThe Journal of Sexual Medicine, 2016
- TGF-β: the master regulator of fibrosisNature Reviews Nephrology, 2016
- Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosisRedox Biology, 2015
- Peyronie’s Disease: A Review of Etiology, Diagnosis, and ManagementCurrent Sexual Health Reports, 2015
- Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2015
- The Basic Principles of Chimeric Antigen Receptor DesignCancer Discovery, 2013
- Cellular Mechanisms of Tissue Fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosisAmerican Journal of Physiology-Cell Physiology, 2013
- Rat as an animal model for Peyronie's disease research: a review of current methods and the peer-reviewed literatureInternational Journal Of Impotence Research, 2011
- A new mouse model of Peyronie's disease: An increased expression of hypoxia-inducible factor-1 target genes during the development of penile changesThe International Journal of Biochemistry & Cell Biology, 2008
- Role and interaction of connective tissue growth factor with transforming growth factor-? in persistent fibrosis: A mouse fibrosis modelJournal of Cellular Physiology, 1999